J&J global recruiting on the rise
Alphamatician on vaccine developers Johnson & Johnson, Pfizer, and Moderna.
Alphamatician is monitoring the impact of COVID-19 on jobs, customer engagement, and pricing.
We looked at global corporate job postings of pharma companies Johnson & Johnson (NYSE: JNJ) and Pfizer Inc. (NYSE: PFE), and the drug and vaccine developer Moderna Inc. (NASDAQ: MRNA). All three have been in the news recently with reference to their progress developing a Coronavirus vaccine.
J&J job postings have trended up consistently over the last 4 months, while Pfizer has been flat.
Moderna postings have fluctuated. It is much smaller and relatively undiversified compared to J&J and Pfizer. But hiring relative to its size is high: 197 open positions as of 10/26/2020 for a work force of about 1000 (per corporate website). The workforces of J&J and Pfizer are, respectively, 132,000 and 88,000 (2019 figures).
When viewed through the filter of US postings related to drug research, these three companies are surprisingly similar. Matching to a set of common job title search terms, open positions in the US related to drug research are as follows: J&J: 168, Pfizer: 167, Moderna: 60. (Data not shown in chart.)
We provide distinctive and exclusive data services to help hedge funds and mutual funds. Contact us to learn how we can help you generate alpha.
www.alphamatician.com
Author: Peter Benda; https://www.dhirubhai.net/in/peterbenda/
#vaccine #pharmaceuticals #clinicaltrial #covid19 #covid19economy #covid19impacts #coronavirusupdates #labormarket #alpha #hiringtrends #datasets #unemployment #alphamatician #employment #UnitedStates